Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-FR Version v9-EN
Language French English
Date Updated 2019-04-15 2019-03-15
Drug Identification Number 02293579 02293579
Brand name RAN-CEFPROZIL RAN-CEFPROZIL
Common or Proper name RAN-CEFPROZIL RAN-CEFPROZIL
Company Name SUN PHARMA CANADA INC SUN PHARMA CANADA INC
Ingredients CEFPROZIL CEFPROZIL
Strength(s) 250MG 250MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 75 mL 75 mL
ATC code J01DC J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-01-07 2019-01-07
Estimated end date 2019-04-18 2019-03-22
Actual end date 2019-04-12
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments